Form 4 for INDP Indaptus Therapeutics, Inc.
Accepted 2022-06-07 00:00:00 ET · period of report 2022-06-06 · accession 0001493152-22-016027 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-06-07 | 2022-06-06 | INDP | Meckler Jeffrey A | CEO, Dir | P - Purchase | $2.63 | +19.7K | 45.4K | +77% | +$51.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common stock | 2022-06-06 | P | A | 19,727 | $2.63 | 45,374 | D | — | — |